Quick Summary

Walnut leaf (Juglans regia) contains multiple bioactive compounds including ellagitannins and polyphenols. These compounds have been studied for potential therapeutic effects, notably in glycemic control for type 2 diabetes mellitus and blood lipid management. Clinical trials and meta-analyses show some evidence suggesting benefits on blood glucose and lipid parameters. Walnut leaf extracts are generally well tolerated in human studies. However, evidence regarding safety, drug interactions, contraindications, and use during pregnancy or breastfeeding remains limited and inconclusive. More robust, large-scale clinical trials are needed to confirm its efficacy and safety.

What Is It?

Walnut leaf refers to the leaves of the walnut tree (Juglans regia), which is native to regions in Asia and Europe. Traditionally used in various herbal preparations, the leaves are rich in bioactive substances such as ellagitannins and polyphenolic compounds, which contribute to their studied biological activities.

Traditional Uses

Historically, walnut leaf has been used in traditional medicine systems for managing blood sugar levels, supporting bone health and osteoporosis, and for general anti-inflammatory purposes. It is also included in some traditional Chinese medicine formulations targeting bone metabolism.

Active Compounds

  • Ellagitannins
  • Polyphenols
  • Urolithins (metabolites of ellagitannins)

Potential Benefits with Evidence Levels

Glycemic Control in Type 2 Diabetes Mellitus

Evidence level: Human clinical evidence

A systematic review and meta-analysis of 4 randomized controlled trials (195 participants) indicated that walnut leaf extract supplementation may significantly reduce fasting blood glucose and increase fasting insulin levels in patients with type 2 diabetes mellitus. However, no significant effect on lipid parameters was observed, and some heterogeneity between studies exists.

Improvement of Blood Lipid Profile

Evidence level: Human clinical evidence

Systematic reviews and meta-analyses of 49 randomized controlled trials involving 4611 participants assessing walnut consumption (including the nuts but not specifically the leaf) suggest reductions in total cholesterol, LDL cholesterol, and triglycerides. Effects on HDL cholesterol and apolipoproteins A1 and B were inconclusive. Some dose-dependent effects were reported.

Antioxidant and Anti-Inflammatory Effects

Evidence level: Preclinical and some clinical evidence

Walnut ellagitannins and their metabolites, urolithins, have shown antioxidant, anti-inflammatory, cardioprotective, neuroprotective, and chemopreventive properties in preclinical studies with limited supporting clinical data. Bioavailability challenges limit circulating levels, and further research is required.

Potential Bone-Protective and Osteoporosis Management Effects

Evidence level: Traditional use and preclinical evidence

Walnut leaf has been used in traditional medicine formulations for osteoporosis management. While direct clinical evidence on walnut leaf alone is limited, some traditional Chinese medicine formulas containing related ingredients indicate beneficial effects on bone metabolism.

Oral Health

Evidence level: Insufficient evidence specific to walnut leaf

General reviews of medicinal plants suggest antimicrobial, anti-inflammatory, and antioxidant activities beneficial to oral health, but specific clinical data on walnut leaf are lacking.

Side Effects

Walnut leaf extracts have been generally well tolerated in clinical trials, with no serious adverse events reported. Mild gastrointestinal discomfort has been reported sporadically but not consistently. Due to limited data, rare or long-term adverse effects cannot be completely excluded.

Drug Interactions

No specific drug interactions with walnut leaf extract have been documented. However, caution is advised when co-administered with antidiabetic medications due to potential additive effects on blood glucose levels.

Who Should Avoid It

Individuals who are pregnant or breastfeeding should avoid walnut leaf extracts unless under medical supervision due to insufficient safety data. Use in children and other sensitive populations has not been adequately studied and should be approached with caution.

Evidence Limitations

The current clinical evidence is limited by small sample sizes, short study durations, and variability in extract preparations and target populations. Much research focuses on walnut nut consumption rather than walnut leaf extracts specifically. Preclinical findings are promising but not definitive for clinical use. High-quality, large-scale randomized controlled trials are necessary to confirm efficacy and safety.

References

Last Reviewed

June 2024

Informational disclaimer: This content is provided for educational and informational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Consult your healthcare provider before using herbal supplements, especially if you are pregnant, breastfeeding, have underlying health conditions, or are taking medications.